 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the following upcoming virtual investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference on Monday, November 29; fireside chat at 10:00 a.m. Eastern Time. 4th Annual 